Adagene is a Nasdaq-listed, international, clinical-stage immunotherapy firm that is reinventing antibody discovery and design to pave the way for future advancements in the fight against cancer. We develop innovative antibodies that get around safety problems and boost effectiveness to give more cancer patients hope, all thanks to a robust platform integrating computational biology and artificial intelligence.
